To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti-SSA/Ro
J Am Heart Assoc
.
2022 Jul 5;11(13):e025580.
doi: 10.1161/JAHA.122.025580.
Epub 2022 Jun 22.
Authors
Jill Buyon
1
,
Amit Saxena
1
,
Deborah Friedman
2
,
Peter Izmirly
1
Affiliations
1
Division of Rheumatology Department of Medicine New York University Grossman School of Medicine New York NY.
2
Department of Pediatrics New York Medical College Valhalla NY.
PMID:
35730612
PMCID:
PMC9333387
DOI:
10.1161/JAHA.122.025580
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Antibodies, Antinuclear*
Autoantibodies
Fetus
Humans
Lupus Erythematosus, Systemic*
Substances
Antibodies, Antinuclear
Autoantibodies
Grants and funding
N01 AR042220/AR/NIAMS NIH HHS/United States
R01 HD079951/HD/NICHD NIH HHS/United States
N01AR42271/AR/NIAMS NIH HHS/United States
R03 HD069986/HD/NICHD NIH HHS/United States